TY - JOUR
T1 - Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury
T2 - Attenuation with riluzole pretreatment
AU - Springer, Joe E.
AU - Azbill, Robert D.
AU - Kennedy, Sarah E.
AU - George, Jones
AU - Geddes, James W.
PY - 1997/10
Y1 - 1997/10
N2 - Immunocytochemical and immunoblotting techniques were used to investigate calpain I activation and the stability of the calpain-sensitive cytoskeletal proteins microtubule-associated protein 2 (MAP2) and spectrin at 1, 4, and 24 h after contusion injury to the spinal cord. Spinal cord injury resulted in the activation of cal-pain I at all time points examined, with the highest level of activation occurring at 1 h. At the same early time point, there was a loss of dendritic MAP2 staining in spinal cord sections, accompanied by pronounced perikaryal accumulation. The loss in MAP2 staining in the injured spinal cord progressed over the 24-h survival period to affect regions 3 mm distant to the site of injury. The presence of calpain I- specific spectrin degradation was apparent in neuronal cell bodies and fibers as early as 1 h after injury, with the most intense staining occurring within and juxtaposed to the injury site. Spectrin break-down products in neuronal cell bodies declined rapidly at 4 h and were nearly undetectable at 24 h after injury. Immunoblot studies confirmed the immunocytochemical results by demonstrating a significant increase in calpain I activation, a significant decrease in MAP2 levels, and a significant increase in spectrin breakdown. Finally, treatment of animals with riluzole, an inhibitor of glutamate release, before surgery reduced significantly the loss of MAP2 levels observed at 24 h after injury. These results demonstrate that Ca2+ - dependent protease activation and degradation of critical cytoskeletal proteins are early events after spinal cord injury and that treatments that minimize the actions of glutamate may limit their breakdown.
AB - Immunocytochemical and immunoblotting techniques were used to investigate calpain I activation and the stability of the calpain-sensitive cytoskeletal proteins microtubule-associated protein 2 (MAP2) and spectrin at 1, 4, and 24 h after contusion injury to the spinal cord. Spinal cord injury resulted in the activation of cal-pain I at all time points examined, with the highest level of activation occurring at 1 h. At the same early time point, there was a loss of dendritic MAP2 staining in spinal cord sections, accompanied by pronounced perikaryal accumulation. The loss in MAP2 staining in the injured spinal cord progressed over the 24-h survival period to affect regions 3 mm distant to the site of injury. The presence of calpain I- specific spectrin degradation was apparent in neuronal cell bodies and fibers as early as 1 h after injury, with the most intense staining occurring within and juxtaposed to the injury site. Spectrin break-down products in neuronal cell bodies declined rapidly at 4 h and were nearly undetectable at 24 h after injury. Immunoblot studies confirmed the immunocytochemical results by demonstrating a significant increase in calpain I activation, a significant decrease in MAP2 levels, and a significant increase in spectrin breakdown. Finally, treatment of animals with riluzole, an inhibitor of glutamate release, before surgery reduced significantly the loss of MAP2 levels observed at 24 h after injury. These results demonstrate that Ca2+ - dependent protease activation and degradation of critical cytoskeletal proteins are early events after spinal cord injury and that treatments that minimize the actions of glutamate may limit their breakdown.
KW - CNS injury
KW - Calcium
KW - Calpain I
KW - Cytoskeleton
KW - Glutamate
KW - Microtubule-associated protein 2
KW - Riluzole
KW - Spectrin
UR - http://www.scopus.com/inward/record.url?scp=0030930824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030930824&partnerID=8YFLogxK
U2 - 10.1046/j.1471-4159.1997.69041592.x
DO - 10.1046/j.1471-4159.1997.69041592.x
M3 - Article
C2 - 9326288
AN - SCOPUS:0030930824
SN - 0022-3042
VL - 69
SP - 1592
EP - 1600
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 4
ER -